Ilagan, Venjie A.

HRN: 27-77-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2025
CEFTRIAXONE 1G (VIAL)
09/10/2025
09/16/2025
IVT
1.5g
Q24
Systemic Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Disseminated Systemic InfectionUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines